Overview / Abstract: |
Target Audience Program Overview Learning Objectives Evaluate and integrate the latest clinical evidence and guidance surrounding the use of newly approved and investigational DMTs in MS patients under the age of 18 when tailoring and monitoring regimens for adolescents |
Expiration |
May 27, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.0 |
Accreditation |
ACCME, ACPE, ANCC |
Presenters / Authors / Faculty |
Brenda Banwell, MD, FRCPC, FAAN |
Sponsors / Supporters / Grant Providers |
Sanofi Genzyme and Biogen Idec |
Keywords / Search Terms |
Relias LLC Relias, Free CME, MS Free CE CME |